Trellus Health (TRLS) Competitors GBX 0.56 -0.01 (-1.57%) As of 11:24 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock TRLS vs. IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHCShould you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry. Trellus Health vs. Its Competitors IQ-AI DeepVerge Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Cambridge Cognition Induction Healthcare Group Trellus Health (LON:TRLS) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, earnings, valuation, institutional ownership, risk, profitability and analyst recommendations. Which has higher earnings and valuation, TRLS or IQAI? IQ-AI has higher revenue and earnings than Trellus Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrellus Health£114K8.00-£7.98M-£0.05-11.30IQ-AI£538.19K3.30N/AN/AN/A Does the media prefer TRLS or IQAI? In the previous week, IQ-AI had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for IQ-AI and 0 mentions for Trellus Health. Trellus Health's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score. Company Overall Sentiment Trellus Health Neutral IQ-AI Neutral Do institutionals and insiders believe in TRLS or IQAI? 6.2% of Trellus Health shares are held by institutional investors. 21.5% of Trellus Health shares are held by insiders. Comparatively, 66.0% of IQ-AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk & volatility, TRLS or IQAI? Trellus Health has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500. Comparatively, IQ-AI has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Is TRLS or IQAI more profitable? IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets Trellus Health-12,114.55% -37.95% -22.76% IQ-AI -77.52%-140.75%-22.03% SummaryIQ-AI beats Trellus Health on 6 of the 10 factors compared between the two stocks. Get Trellus Health News Delivered to You Automatically Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRLS vs. The Competition Export to ExcelMetricTrellus HealthHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£913K£348.34M£5.75B£2.58BDividend YieldN/A5.88%5.69%5.30%P/E Ratio-11.30506.5374.935,404.14Price / Sales8.00248.66452.3596,701.95Price / Cash0.7647.1425.8127.93Price / Book0.065.1213.258.78Net Income-£7.98M-£15.55M£3.29B£5.89B7 Day Performance7.62%1.65%0.47%0.56%1 Month Performance-25.17%1.69%4.60%44.71%1 Year Performance-49.78%12.70%73.42%174.03% Trellus Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRLSTrellus HealthN/AGBX 0.57-1.6%N/A-49.0%£913K£114K-11.3031Gap UpIQAIIQ-AIN/AGBX 0.80flatN/A-33.3%£1.77M£538.19K-13.676News CoverageGap UpDVRGDeepVergeN/AN/AN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AN/AN/AN/A£583K£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware2.0292 of 5 starsGBX 2,270-5.4%GBX 2,725+20.0%+1.8%£803.81M£198.10M5,341.18734News CoverageAnalyst ForecastINSInstemN/AN/AN/AN/A£199.62M£61.63M5,928.57500KOOKooth1.888 of 5 starsGBX 153+0.3%GBX 456.67+198.5%N/A£54.85M£66.74M728.57478RENXRenalytixN/AGBX 5.75-1.7%N/AN/A£19.04M£2.37M-35.94102Gap DownCOGCambridge CognitionN/AGBX 35flatN/A-10.3%£16.09M£9.05M-921.0580Gap UpINHCInduction Healthcare GroupN/AGBX 9.75flatN/A+23.4%£9.00M£12.57M-1.7674 Related Companies and Tools Related Companies IQAI Competitors DVRG Competitors SENS Competitors EMIS Competitors CRW Competitors INS Competitors KOO Competitors RENX Competitors COG Competitors INHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:TRLS) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trellus Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trellus Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
